Deeter RG - Search Results

1

Prevalence of abnormal cardiac wall motion in the cardiomyopathy associated with incomplete multiplication of Epstein-barr Virus and/or cytomegalovirus in patients with chronic fatigue syndrome.

Lerner AM, Dworkin HJ, Sayyed T, Chang CH, Fitzgerald JT, Beqaj S, Deeter RG, Goldstein J, Gottipolu P, O'Neill W. Lerner AM, et al. Among authors: deeter rg. In Vivo. 2004 Jul-Aug;18(4):417-24. In Vivo. 2004. PMID: 15369178 Free article.

2

IgM serum antibodies to human cytomegalovirus nonstructural gene products p52 and CM2(UL44 and UL57) are uniquely present in a subset of patients with chronic fatigue syndrome.

Lerner AM, Beqaj SH, Deeter RG, Fitzgerald JT. Lerner AM, et al. Among authors: deeter rg. In Vivo. 2002 May-Jun;16(3):153-9. In Vivo. 2002. PMID: 12182109

3

A six-month trial of valacyclovir in the Epstein-Barr virus subset of chronic fatigue syndrome: improvement in left ventricular function.

Lerner AM, Beqaj SH, Deeter RG, Dworkin HJ, Zervos M, Chang CH, Fitzgerald JT, Goldstein J, O'Neill W. Lerner AM, et al. Among authors: deeter rg. Drugs Today (Barc). 2002 Aug;38(8):549-61. doi: 10.1358/dot.2002.38.8.820095. Drugs Today (Barc). 2002. PMID: 12582420 Review.

4

IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome.

Lerner AM, Beqaj SH, Deeter RG, Fitzgerald JT. Lerner AM, et al. Among authors: deeter rg. In Vivo. 2004 Mar-Apr;18(2):101-6. In Vivo. 2004. PMID: 15113035 Free article.

5

Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up.

Lerner AM, Beqaj SH, Deeter RG, Fitzgerald JT. Lerner AM, et al. Among authors: deeter rg. In Vivo. 2007 Sep-Oct;21(5):707-13. In Vivo. 2007. PMID: 18019402 Free article. Clinical Trial.

6

A small, randomized, placebo-controlled trial of the use of antiviral therapy for patients with chronic fatigue syndrome.

Lerner AM, Zervos M, Chang CH, Beqaj S, Goldstein J, O'Neill W, Dworkin H, Fitgerald T, Deeter RG. Lerner AM, et al. Among authors: deeter rg. Clin Infect Dis. 2001 Jun 1;32(11):1657-8. doi: 10.1086/320530. Clin Infect Dis. 2001. PMID: 11340544 Clinical Trial. No abstract available.

7

Pharmacokinetics and safety of valaciclovir in children with Epstein-Barr virus illness.

Simon MW, Fish DN, Deeter RG. Simon MW, et al. Among authors: deeter rg. Drugs R D. 2002;3(6):365-73. doi: 10.2165/00126839-200203060-00001. Drugs R D. 2002. PMID: 12516939 Clinical Trial.

8

Valacyclovir therapy to reduce recurrent genital herpes in pregnant women.

Andrews WW, Kimberlin DF, Whitley R, Cliver S, Ramsey PS, Deeter R. Andrews WW, et al. Am J Obstet Gynecol. 2006 Mar;194(3):774-81. doi: 10.1016/j.ajog.2005.11.051. Am J Obstet Gynecol. 2006. PMID: 16522412 Clinical Trial.

9

Stability of valacyclovir hydrochloride in extemporaneously prepared oral liquids.

Fish DN, Vidaurri VA, Deeter RG. Fish DN, et al. Among authors: deeter rg. Am J Health Syst Pharm. 1999 Oct 1;56(19):1957-60. doi: 10.1093/ajhp/56.19.1957. Am J Health Syst Pharm. 1999. PMID: 10554914

10

Recent advances in antiviral therapy.

Deeter RG, Khanderia U. Deeter RG, et al. Clin Pharm. 1986 Dec;5(12):961-76. Clin Pharm. 1986. PMID: 3542344 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters